<body><p>HR 589 IH</p><p/><center><p>113th CONGRESS</p></center>
<p/><center><p>1st Session</p></center>
<p/><center><p>H. R. 589</p></center>
<p>To amend the National Organ Transplant Act to prevent the sale of bone marrow and umbilical cord blood, and for other purposes.</p><p/><center><p>IN THE HOUSE OF REPRESENTATIVES</p></center>
<p/><h3><center><p>February 6, 2013</p></center></h3>
<p>Mr. YOUNG of Florida (for himself and Ms. MATSUI) introduced the following bill; which was referred to the Committee on Energy and Commerce</p><hr/><p/><center><p>A BILL</p></center>
<p>To amend the National Organ Transplant Act to prevent the sale of bone marrow and umbilical cord blood, and for other purposes.</p><ul><p><em>  Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,</em></p></ul><p/><h3>SECTION 1. AMENDMENT TO THE NATIONAL ORGAN TRANSPLANT ACT TO PREVENT THE SALE OF BONE MARROW AND UMBILICAL CORD BLOOD.</h3>
<ul><p>Paragraph 1 of section 301(c) of the National Organ Transplant Act (42 U.S.C. 274e(c)) is amended--</p><ul><p>(1) by inserting &#8216;(as defined in section 379A-1 of the Public Health Service Act (42 U.S.C. 274l-1))&#8217; after &#8216;bone marrow&#8217;; and</p><p>(2) by inserting &#8216;, a cord blood unit (as defined in section 2(g) of the Stem Cell Therapeutic and Research Act of 2005 (42 U.S.C. 274k note)),&#8217; after &#8216;skin or any subpart therof&#8217;.</p></ul></ul></body>